Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)
China flag China · Delayed Price · Currency is CNY
74.50
-0.71 (-0.94%)
At close: Jan 22, 2026

Revenue by Product

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202013 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2013 - 2019
Non-immunization Program Vaccines
1.33B
Log In
Log In
Log In
Log In
Upgrade
Non-immunization Program Vaccines Growth
-15.93%
Log In
Log In
Log In
Log In
Upgrade
Other
106.14M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
3743928.60%
Log In
Log In
Log In
Log In
Upgrade
Veterinary Vaccine
-
Log In
Log In
Log In
Log In
Upgrade
Veterinary Vaccine Growth
-
Log In
Log In
Log In
Log In
Upgrade
Lyophilized Human Rabies Vaccine (Human Diploid Cells)
-
Log In
Log In
Log In
Log In
Upgrade
Lyophilized Human Rabies Vaccine (Human Diploid Cells) Growth
-
Log In
Log In
Log In
Log In
Upgrade
ACYW135 Meningococcal Polysaccharide Vaccine
-
Log In
Log In
Log In
Log In
Upgrade
ACYW135 Meningococcal Polysaccharide Vaccine Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202013 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2013 - 2019
China
1.33B
Log In
Log In
Log In
Log In
Upgrade
China Growth
-15.84%
Log In
Log In
Log In
Log In
Upgrade
Overseas
106.24M
Log In
Log In
Log In
Log In
Upgrade
Overseas Growth
4657.11%
Log In
Log In
Log In
Log In
Upgrade